Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. 1993

E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
Department of Rheumatology and Immunology, Tan Tock Seng Hospital, Singapore.

OBJECTIVE To determine possible similarities and differences in clinical and laboratory features and treatment response between patients in Singapore with polymyositis (PM) and dermatomyositis (DM) and reported series. METHODS Case records of adult patients (16 years old and above) referred to the 3 main electromyographic (EMG) laboratories in Singapore between 1 June 1986 and 31 May 1991 were reviewed if the referring diagnosis was myositis or myopathy for investigation. A computer search for adult patients with a diagnosis of PM/DM (ICD codes 710.3, 710.4, 517.8) who attended the main rheumatology and neurology centre during this period was also carried out. The criteria for PM/DM proposed by Bohan and Peter was adopted. RESULTS The incidence of PM/DM was 7.7 cases per million population per year. There were 35 PM and 40 DM cases with a median age at diagnosis of 50.7 years (SD: 16.7) and significantly more females in the PM group (p < 0.05). At presentation, 86.7% had proximal myopathy, 34.7% had arthralgia/arthritis and 18.7% had cutaneous vasculitis. The creatine kinase level was elevated in 89.3% of patients and positive EMG and muscle biopsy in 79.4% and 76.4% respectively. Systemic lupus erythematosus was the commonest associated connective tissue disease. The percentage of patients with malignancy was higher in DM compared with PM (p < 0.01) and they were significantly older (mean age 61.8 years) (p < 0.001). Patients who achieved remission were significantly younger (mean age 46.4 years, p < 0.05). The overall mortality rate was 26.7% with infection and malignancy as the main causes of death. CONCLUSIONS The results of the study suggest ethnicity does not influence the expression of PM/DM in view of the considerable similarities in frequency and clinical expression of disease in the population studied compared with series from other countries.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003882 Dermatomyositis A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6) Polymyositis-Dermatomyositis,Dermatomyositis, Adult Type,Dermatomyositis, Childhood Type,Dermatopolymyositis,Juvenile Dermatomyositis,Juvenile Myositis,Adult Type Dermatomyositis,Childhood Type Dermatomyositis,Dermatomyositis, Juvenile,Myositis, Juvenile,Polymyositis Dermatomyositis
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
February 1986, Seminars in arthritis and rheumatism,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
October 1990, Seminars in arthritis and rheumatism,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
April 1985, The Journal of rheumatology,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
March 1985, Canadian Medical Association journal,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
November 2022, American journal of reproductive immunology (New York, N.Y. : 1989),
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
May 2011, Rheumatic diseases clinics of North America,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
January 2012, Reumatizam,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
November 2001, Annales de medecine interne,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
January 2012, Reumatizam,
E T Koh, and A Seow, and B Ong, and P Ratnagopal, and H Tjia, and H H Chng
January 1988, Clinics in dermatology,
Copied contents to your clipboard!